Betamethasone valerate
![]() | |
| Clinical data | |
|---|---|
| Trade names | Betnovate, Celestoderm, Ecoval 70, Hormezon |
| Other names | Betamethasone 17-valerate |
| AHFS/Drugs.com | Monograph |
| Drug class | Corticosteroid; glucocorticoid |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.016.764 |
| Chemical and physical data | |
| Formula | C27H37FO6 |
| Molar mass | 476.585 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Betamethasone valerate is a synthetic glucocorticoid ester. It is the 17-valerate ester of betamethasone.[1][2] Betamethasone valerate is often used to treat mild eczema with good efficacy and lower incidence of steroid induced adverse effects due to its lower potency compared to other glucocorticoids.[3] Betamethasone-17-valerate is available in cream, ointment, lotion, and foam preparations for topical use.[3][4][5]
See also
References
- ^ Ly S, Amici JM (2018). "Role of betamethasone valerate 2.250 mg medicated plaster in the treatment of psoriasis and other dermatological pathologies: a review". Drugs in Context. 7: 212539. doi:10.7573/dic.212539. PMC 6104053. PMID 30151017.
- ^ "Betamethasole valerate". PubChem. U.S. National Library of Medicine.
- ^ a b Raveendran R (November 2019). "Tips and Tricks for Controlling Eczema". Immunology and Allergy Clinics of North America. 39 (4): 521–533. doi:10.1016/j.iac.2019.07.006. PMID 31563186. S2CID 202816063.
- ^ Payne J, Habet KA, Pona A, Feldman SR (August 2019). "A Review of Topical Corticosteroid Foams". Journal of Drugs in Dermatology. 18 (8): 756–770. PMID 31424707.
- ^ Duweb GA, Abuzariba O, Rahim M, al-Taweel M, Abdulla SA (2000). "Scalp psoriasis: topical calcipotriol 50 micrograms/g/ml solution vs. betamethasone valerate 1% lotion". International Journal of Clinical Pharmacology Research. 20 (3–4): 65–68. PMID 11314240.
